A REVIEW OF SODIUM PENTOBARBITAL SOLUBILITY

Contraindicated (one)pentobarbital will decrease the extent or effect of lumefantrine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with robust CYP3A4 inducers may result in lowered serum concentrations and lack of antimalarial efficacypentobarbital will minimize the level or effect of ibuprofen by affe